GlassScriptPhysician profile
Peter J Kunkel
NPI 1427090877
$1,605.27
in general payments reported to CMS, 2019-2025
13 companies · $58.68 in 2025
The $58.68 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.13 · 2022: $802 · 2023: $179 · 2024: $516 · 2025: $58.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698 · Debt Forgiveness: $55.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.26 |
| Debt Forgiveness | $55.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $563.30 | 2022-2025 | Mitraclip, Gallant, Assurity |
| Shockwave Medical, INC | $399.98 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $305.52 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $70.06 | 2023-2024 | Camzyos |
| Baxter Healthcare | $55.76 | 2023 | |
| Scpharmaceuticals INC. | $48.79 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $41.81 | 2023-2024 | |
| Cvrx, INC. | $23.03 | 2024 | Barostim Neo System |
| Abiomed | $21.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.28 | 2023 | Jardiance |
| Amgen INC. | $20.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.56 | 2023 | Xarelto |
| Boston Scientific Corporation | $13.94 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kunkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.